Insulet said revenue for Q1 2025 (3 months) was $569.0 million, up 28.8% from $441.7 million a year earlier, and up 29.8% in constant currency.

1. 01

   Insulet said revenue for Q1 2025 (3 months) was $569.0 million, up 28.8% from $441.7 million a year earlier, and up 29.8% in constant currency.

2. 02

   Insulet said operating income for Q1 2025 was $88.8 million (15.6% of revenue), up from $56.9 million (12.9%) a year earlier, while net income was $35.4 million ($0.50 per diluted share), down from $51.5 million ($0.73) a year earlier.

3. 03

   The company said operating cash flow for Q1 2025 was $63.8 million, down from $87.6 million a year earlier, and free cash flow was $51.5 million, down from $65.5 million a year earlier.

4. 04

   The company set its constant-currency total revenue growth outlook for full-year 2025 at 19% to 22%, versus its prior outlook of 16% to 20% as of February 20, 2025. It set its gross margin outlook at about 71%, versus about 70.5% previously.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.